Peripheral Angioplasty and Stenting Market Size, Share, Growth, and Industry Analysis, By Type (Balloon, Stent), By Application (Hospitals, ASCs, Catheterization Laboratory), Regional Insights and Forecast to 2035

Peripheral Angioplasty and Stenting Market Overview

The global Peripheral Angioplasty and Stenting Market size is projected to grow from USD 5464.75 million in 2026 to USD 5825.43 million in 2027, reaching USD 10290.96 million by 2035, expanding at a CAGR of 6.6% during the forecast period.

What is Peripheral Angioplasty and Stenting?

Peripheral Angioplasty and Stenting is a minimally invasive medical procedure used to treat narrowed or blocked peripheral arteries, mainly in the legs, arms, or other areas outside the heart. Angioplasty uses a small balloon to widen the blocked artery, while a stent is inserted to keep the blood vessel open and maintain proper blood flow. This procedure is commonly used for patients with peripheral artery disease (PAD) to reduce pain, improve circulation, and lower the risk of severe complications such as tissue damage or limb loss.

The Peripheral Angioplasty and Stenting Market is driven by the treatment of arterial blockages outside coronary vessels, with more than 230 million people affected by peripheral artery disease globally. Peripheral angioplasty procedures exceed 18 million annually, with stenting used in approximately 52% of complex cases. Balloon angioplasty alone accounts for 48% of interventions, primarily in lesions under 80 mm. Femoropopliteal arteries represent 44% of total treated segments, while iliac arteries account for 29%. Technological penetration of drugcoated balloons within peripheral angioplasty reached 41%, strengthening Peripheral Angioplasty and Stenting Market Size, Market Outlook, and Industry Analysis relevance.

The USA Peripheral Angioplasty and Stenting Market contributes nearly 37% of global procedural volume, supported by over 6,800 interventional centers. Peripheral interventions exceed 5.9 million annually, with stent utilization present in 56% of cases involving calcified lesions. Hospitals perform 71% of procedures, ASCs contribute 18%, and catheterization laboratories account for 11%. Lowerextremity angioplasty procedures increased 33% over the last decade, reinforcing Peripheral Angioplasty and Stenting Market Growth and Market Share in the United States.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver :Rising PAD prevalence 46%, minimally invasive preference 52%, repeat intervention reduction 38%, aging population influence 41%.
• Major Market Restraint :Restenosis occurrence 34%, device cost sensitivity 29%, reimbursement variability 31%, procedural complexity 26%.
• Emerging Trends :Drugcoated technology adoption 43%, bioresorbable stent research 27%, imagingassisted angioplasty 36%, hybrid therapy usage 32%.
• Regional Leadership :North America 38%, Europe 31%, AsiaPacific 23%, Middle East & Africa 8%.
• Competitive Landscape :Top two players 55%, midsized manufacturers 30%, emerging companies 15%.
• Market Segmentation :Balloon angioplasty 48%, stenting 52%, hospitals 70%, ASCs 19%, catheterization laboratories 11%.
• Recent Development :Device innovation activity 42%, clinical trials expansion 35%, regulatory approvals 28%, portfolio expansion 31%.

Peripheral Angioplasty and Stenting Market Latest Trends

The Peripheral Angioplasty and Stenting Market Trends indicate increased adoption of minimally invasive vascular interventions, with procedure volumes rising 39% in outpatient settings. Drugcoated balloons are now integrated into 41% of angioplasty cases to reduce restenosis rates by 36%. Selfexpanding stents represent 63% of all peripheral stent usage due to flexibility advantages in long lesions exceeding 120 mm. Imagingguided angioplasty using IVUS and OCT increased 34%, improving procedural accuracy by 29%. Belowtheknee angioplasty adoption grew 27%, driven by limb salvage procedures, strengthening Peripheral Angioplasty and Stenting Market Insights and Market Forecast positioning.

Why is the Peripheral Angioplasty and Stenting Industry Growing?

The industry is growing due to the increasing prevalence of peripheral artery disease, rising aging population, and growing demand for minimally invasive vascular treatments. Improved procedural success and reduced hospitalization time are also supporting market expansion.

Peripheral Angioplasty and Stenting Market Dynamics

DRIVER

"Rising prevalence of peripheral artery disease and aging population"

Peripheral artery disease affects over 230 million individuals globally, with prevalence increasing 42% among patients aged above 60 years. Peripheral angioplasty reduces hospitalization duration by 47% compared to open surgery, while stenting improves vessel patency by 38% in complex lesions. Demand for minimally invasive treatment increased 51%, supporting Peripheral Angioplasty and Stenting Market Growth and Industry Report expansion across both developed and emerging regions.

RESTRAINT

"Restenosis and longterm durability concerns"

Restenosis rates after plain balloon angioplasty remain between 30% and 45%, while instent restenosis affects approximately 22% of stented lesions. Longterm patency beyond 3 years remains inconsistent in 28% of femoropopliteal cases. These limitations slow adoption in 31% of healthcare facilities, impacting Peripheral Angioplasty and Stenting Market Outlook and Market Share stability.

OPPORTUNITY

"Integration of drugcoated and hybrid therapies"

Drugcoated balloonassisted angioplasty reduces target lesion revascularization by 37% and is increasingly used alongside stenting in 34% of complex procedures. Hybrid therapies combining atherectomy with angioplasty increased 29%, particularly in heavily calcified lesions. Emerging markets represent 36% of untreated PAD patients, reinforcing Peripheral Angioplasty and Stenting Market Opportunities and Market Forecast expansion.

CHALLENGE

"Cost pressures and operator dependency"

Procedure costs vary by 41% across regions, influencing adoption in costsensitive markets. Operator skill impacts procedural success in 35% of cases, while learning curves affect outcomes during the first 50–75 procedures. These challenges constrain uniform Peripheral Angioplasty and Stenting Market Growth across regions.

Why is Demand Increasing for Peripheral Angioplasty and Stenting?

Demand is increasing because these procedures provide faster recovery, lower surgical risks, and effective treatment for complex arterial blockages. Growing adoption of drug-coated balloons and advanced stent technologies is also improving patient outcomes and boosting usage globally.

Segmentation Analysis

The Peripheral Angioplasty and Stenting Market Segmentation is defined by type and application. Balloon angioplasty accounts for 48% of procedures, while stents represent 52% due to durability in complex lesions. Hospitals dominate with 70% usage, followed by ASCs at 19% and catheterization laboratories at 11%, reflecting procedural complexity and infrastructure availability.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Type

Balloon

Balloon angioplasty is widely used in peripheral vascular interventions because it provides a minimally invasive method for opening narrowed or blocked arteries. Standard and drug-coated balloons are commonly preferred for treating short lesions and improving blood flow without leaving a permanent implant inside the vessel. The technology is especially effective in peripheral artery disease treatment due to its flexibility, lower procedural complexity, and ability to reduce recovery time for patients undergoing vascular procedures.

Balloon angioplasty accounts for a significant share of the Peripheral Angioplasty and Stenting market, with drug-coated balloons increasingly adopted to reduce restenosis and improve long-term vessel patency. Advancements in balloon materials, lower crossing profiles, and improved deliverability systems are helping physicians treat complex peripheral lesions more effectively. Continuous innovation in balloon technologies is expected to further strengthen adoption across hospitals and outpatient vascular care centers.

Stent

Stents play a major role in peripheral angioplasty procedures by helping maintain vessel openness after arterial blockages are treated. Self-expanding stents are highly preferred in peripheral interventions because of their flexibility and ability to adapt to vessel movement, particularly in long and complex lesions. These devices are commonly used in patients with severe peripheral artery disease where balloon angioplasty alone may not provide durable treatment outcomes.

Stenting represents the larger segment of the market due to its effectiveness in improving long-term vessel patency and reducing repeat interventions. Technological improvements in nitinol stent designs have enhanced durability and lowered fracture risks, supporting wider adoption in peripheral vascular procedures. Covered stents are also gaining importance for iliac artery interventions and complex lesion management, contributing to continued market expansion.

By Application

ASCs

Ambulatory Surgical Centers (ASCs) are becoming increasingly important in the Peripheral Angioplasty and Stenting market because they offer cost-effective and efficient outpatient vascular procedures. These centers provide faster patient turnaround times, reduced hospitalization requirements, and shorter recovery periods, making them attractive for minimally invasive peripheral interventions.

ASCs are witnessing rising adoption of angioplasty procedures due to growing patient preference for same-day discharge and lower treatment costs compared to traditional hospital settings. Improvements in vascular treatment technologies and increasing physician confidence in outpatient procedures are further supporting the growth of ASCs within the peripheral intervention market.

Catheterization Laboratory

Catheterization laboratories are specialized facilities used for diagnosing and treating vascular and cardiovascular conditions through minimally invasive procedures. These laboratories play an important role in managing focal arterial lesions, restenosis cases, and image-guided peripheral interventions using advanced angioplasty and stenting technologies.

The use of catheterization laboratories is increasing due to growing demand for precise vascular imaging and specialized interventional procedures. Advancements in imaging systems, catheter technologies, and minimally invasive treatment approaches are enabling healthcare providers to perform complex peripheral interventions with greater procedural accuracy and improved patient outcomes.

Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America leads the Peripheral Angioplasty and Stenting market due to its advanced healthcare infrastructure, high adoption of minimally invasive vascular procedures, and strong presence of leading medical device manufacturers. The region benefits from a large number of interventional centers and increasing use of advanced technologies such as drug-coated balloons and self-expanding stents for treating peripheral artery disease. Rising awareness of vascular health and growing elderly population are also supporting continuous market growth.

The United States contributes the majority of regional procedures because of higher healthcare spending, strong reimbursement systems, and widespread availability of specialized vascular treatment facilities. Increasing treatment of complex arterial lesions and growing demand for outpatient vascular interventions continue to strengthen the region’s market position globally.

Europe

Europe remains a significant market for peripheral angioplasty and stenting due to well-established healthcare systems and increasing adoption of advanced vascular intervention technologies. Countries such as Germany, France, and the United Kingdom contribute heavily to regional procedural volume because of strong clinical expertise and high prevalence of peripheral artery disease.

The region is witnessing growing use of angioplasty and stenting procedures, especially for iliac and lower-extremity artery treatments. Supportive regulatory frameworks, continuous technological advancements, and increasing physician preference for minimally invasive procedures are helping expand the European peripheral vascular intervention market.

AsiaPacific

Asia-Pacific is experiencing rapid growth in the Peripheral Angioplasty and Stenting market due to rising patient population, increasing cardiovascular disease burden, and improving healthcare accessibility. Countries like China and India are driving regional growth through expanding hospital infrastructure and increasing adoption of advanced vascular treatment procedures.

Government healthcare investments, rising awareness of peripheral artery disease, and growing availability of affordable treatment solutions are supporting wider market penetration across the region. The increasing focus on minimally invasive vascular interventions is also encouraging hospitals and healthcare providers to adopt advanced angioplasty and stenting technologies.

Middle East & Africa

Africa is gradually expanding in the Peripheral Angioplasty and Stenting market due to improving healthcare infrastructure and rising investments in cardiovascular treatment services. Gulf countries are leading regional adoption with increasing procedural volumes and growing availability of specialized vascular care facilities.

Public healthcare initiatives and expanding access to advanced medical technologies are supporting the adoption of peripheral angioplasty and stenting procedures across the region. Rising awareness of peripheral artery disease and increasing demand for minimally invasive vascular treatments are expected to further strengthen market growth in the coming years.

Which Region Dominates the Peripheral Angioplasty and Stenting Industry?

North America dominates the industry with the highest market share due to advanced healthcare infrastructure, strong adoption of drug-coated technologies, and a high number of interventional procedures performed annually.

List of Top Peripheral Angioplasty and Stenting Companies

• Braun
• BD
• Yinyi
• Philips
• Eurocor
• Aachen Resonance
• Biotronic

Top Two Companies with Highest Market Share:

• Medtronic – approximately 32% global market share with presence in 70+ countries
• Boston Scientific – approximately 23% market share with over 50 peripheral device platforms

Investment Analysis and Opportunities

Investment in the Peripheral Angioplasty and Stenting market is increasing as healthcare providers and medical device manufacturers focus on advanced vascular treatment technologies. A large portion of investments is being directed toward drug-coated balloons, bioresorbable stents, and next-generation peripheral intervention devices designed to improve long-term patient outcomes. Companies are also expanding manufacturing automation capabilities to enhance production efficiency, maintain product quality, and reduce operational defects. Growing emphasis on minimally invasive procedures and rising cases of peripheral artery disease are further attracting strategic investments across developed and emerging healthcare markets.

Emerging economies continue to present strong business opportunities due to improving healthcare infrastructure, increasing awareness of vascular diseases, and expanding patient access to advanced treatment procedures. Investments in outpatient vascular care facilities and ambulatory surgical centers are also supporting market expansion by enabling cost-effective and faster treatment options. In addition, partnerships between medical device companies, healthcare institutions, and research organizations are accelerating innovation and strengthening the competitive landscape of the market.

New Product Development

New product development in the Peripheral Angioplasty and Stenting market is advancing rapidly with strong focus on improving procedural efficiency, device flexibility, and patient safety. Manufacturers are introducing next-generation angioplasty balloons with lower crossing profiles that improve navigation through complex and calcified lesions. Enhanced deliverability features are helping physicians perform procedures more effectively in challenging peripheral vascular conditions. Advanced stent platforms are also being developed with improved structural durability to minimize fracture risks and maintain long-term vessel patency.

Technological innovation is additionally focused on imaging-compatible devices and smart catheter systems that improve procedural precision during vascular interventions. Companies are investing heavily in research and development to create safer, more durable, and minimally invasive treatment solutions for peripheral artery disease patients. Growing demand for outpatient procedures and increasing physician preference for advanced vascular devices are encouraging continuous product upgrades and expansion of clinical applications across global healthcare markets.

Five Recent Developments (2023-2025)

• Launch of lowprofile peripheral stents reduced complication rates by 26%
• Expansion of drugcoated balloon indications increased eligible patients by 33%
• Manufacturing upgrades reduced device variability by 24%
• Clinical trial enrollments expanded 39%
• Hybrid therapy adoption increased 29%

Report Coverage of Peripheral Angioplasty and Stenting Marke

This Peripheral Angioplasty and Stenting Market Research Report covers 4 regions, 3 applications, 2 product types, and more than 30 manufacturers. The report evaluates procedural volumes, technology adoption rates, competitive benchmarking, regulatory environments, and clinical performance metrics, delivering datadriven Peripheral Angioplasty and Stenting Market Insights for hospitals, device manufacturers, and institutional investors.

Peripheral Angioplasty and Stenting Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 5464.75 Million in 2026
Market Size Value By	USD 10290.96 Million by 2035
Growth Rate	CAGR of 6.6% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Balloon Stent By Application : Hospitals ASCs Catheterization Laboratory
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample